Share with friends

Now that you're in the know about Carac® and AKs, tell a friend.

Indication

Carac® is indicated for the topical treatment of multiple actinic or solar keratoses of the face and anterior scalp.

For more information, please see Full Prescribing Information for Carac®.

Important Treatment Considerations for Carac®

  • Carac® is for external use only.
  • Avoid contact with eyes, eyelids, nostrils, and mouth.
  • Cleanse affected area and wait 10 minutes before applying Carac®.
  • Wash hands immediately after applying Carac®.
  • Avoid prolonged exposure to sunlight or other forms of ultraviolet irradiation during treatment, as the intensity of the reaction may be increased.
  • Most patients using Carac® get skin reactions where the medicine is used. These reactions include redness, dryness, burning, pain, erosion (loss of the upper layer of skin), and swelling. Irritation at the application site may persist for two or more weeks after therapy is discontinued. Treated areas may be unsightly during and after therapy.
  • If you develop abdominal pain, bloody diarrhea, vomiting, fever, or chills while on Carac® therapy, stop the medication and contact your physician and/or pharmacist.
  • Report any side effects to the physician and/or pharmacist.

Important Safety Information for Carac®

Carac® should not be used by women who are pregnant, considering becoming pregnant, or nursing. Carac® should not be used by people with dihydropyrimidine dehydrogenase (DPD) enzyme deficiency or in people allergic to any of the ingredients in the product. If you develop abdominal pain, diarrhea, vomiting, fever, or chills while using Carac®, stop the medication immediately and contact your doctor.

Carac® is for external use only. Avoid contact with the eyes, eyelids, nostrils, and mouth. Wash hands immediately after applying Carac®. Avoid prolonged exposure to sunlight or other forms of UV light.

Most patients using Carac® get skin reactions where the medicine is used, and the treatment areas may become unsightly during and after therapy. The most common skin reactions include redness, dryness, burning, pain, erosion (loss of upper layer of skin), swelling and eye irritation. These skin reactions can last for two or more weeks after therapy is discontinued.

Healthcare Professionals

This information is intended for U.S. Healthcare Professionals only.

Are you a U.S. Healthcare Professional?